In English
NIDA

Search

Menu

Investigaciones sobre los tratamientos

Intervention Improves Employment Outlook For Methadone Patients

Describes a study of unemployed methadone patients and the use of assertive outreach and motivational techniques to improve the patients’ employment outlook.

New Therapy Reduces Drug Abuse Among Patients With Severe Mental Illness

Describes a new intervention that enhances recovery prospects for substance abusers whose mental illness complicates the path toward recovery.

Linking NIDA to Researchers on a Global Scale

Highlights the NIDA International Program which works to strengthen international research networks, creating opportunities for global research collaboration, training, and scientific exchange.

NIDA Renames Addiction Journal

Alerts readers to the new renamed journal, Addiction Science and Clinical Practice, formerly titled Science and Practice Perspectives.

Social Neuroscience Meeting Aims to Improve Prevention, Treatment

Presents highlights of a meeting of scientists and clinicians to review research results from the field of social neuroscience, the study of how neurobiology and the social environment interact.

Research Breakthroughs in Drug Abuse Have Wide Applications in Other Fields

NIDA Director Nora Volkow

Offers an overview of some of the NIDA-supported innovative research achievements to reduce the health and social effects of drug abuse and addiction.

Basic Science Discoveries Yield Novel Approaches to Analgesia

Describes research to develop new compounds that match or exceed the pain relief provided by opioids while avoiding their shortcomings.

Henry Yamamura Obituary

Remembers Henry I. "Hank" Yamamura, an eminent neuropharmacologist who pioneered radioligand binding assays, contributing valuable knowledge about neurotransmitter transporters and receptors.

Lofexidine May Enhance Naltrexone Efficacy

Highlights results from a pilot study suggesting that lofexidine, an anti-hypertensive medication, can enhance success rates among patients taking maintenance naltrexone to avoid opioid relapse.

Selenium Shows Promise as an Adjunct Therapy for HIV

Reports on a randomized controlled trial of HIV-infected men and women who, as a result of receiving selenium supplements, experienced lower HIV viral load and greater CD4 cell count.

Pages

Subscribe to RSS - Investigaciones sobre los tratamientos

Toma el reto nacional sobre el coeficiente intelectual (CI) sobre las drogas